Welcome to our dedicated page for National Healthcare Properties SEC filings (Ticker: NHPBP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on National Healthcare Properties's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into National Healthcare Properties's regulatory disclosures and financial reporting.
National Healthcare Properties, Inc. is making several governance changes and ending its shareholder rights plan early. The company amended its rights agreement so that the existing common share purchase rights now expire on January 12, 2026, removing this anti-takeover protection sooner than originally scheduled.
The board approved a move to a fully declassified structure so that all directors will stand for annual election beginning with the 2026 annual meeting. It also adopted amended and restated bylaws that address SEC universal proxy rules, tighten procedural and disclosure requirements for stockholder nominations and proposals, and add proxy access for qualifying long-term stockholders. The company elected independent director Scott Humphrey to the board and as chair of the Audit Committee, merged its nominating and compensation functions into a single Compensation and Corporate Governance Committee, and expanded its opt-out from Maryland’s business combination restrictions to cover business combinations with any person.
This filing is an initial ownership report for an officer of National Healthcare Properties, Inc., serving as Chief Accounting Officer. The report states that, as of the event date of 12/22/2025, the reporting person has no securities beneficially owned in the company. The form is filed by a single reporting person, and a Power of Attorney (Exhibit 24.1) authorizes Jie Chai to sign on the reporting person’s behalf.
National Healthcare Properties, Inc. entered into a new unsecured credit agreement on December 11, 2025, for a $400 million revolving credit facility and a $150 million term loan. These credit facilities, guaranteed by the company and certain subsidiaries, replace a prior secured term loan that was paid off at closing.
The facilities mature on December 11, 2028, with options to extend for up to two additional one-year periods, and may be increased by up to $450 million subject to conditions. Borrowings will bear interest at either a base rate plus a margin of
National Healthcare Properties, Inc. filed an initial Form 3 for its Chief Financial Officer, indicating their status as an officer subject to Section 16 reporting. The filing states that the reporting person does not beneficially own any non-derivative or derivative securities of the company. The form is filed by one reporting person, with a power of attorney documented as Exhibit 24.1, and relates to an event dated 11/18/2025.
National Healthcare Properties, Inc. announced a leadership change in its finance organization. On November 18, 2025, the Board appointed Andrew T. Babin as Chief Financial Officer and Treasurer, replacing Scott M. Lappetito, who resigned the same day and whose resignation was stated not to result from any disagreement on management, operations or financial matters.
Under his employment agreement, Mr. Babin will receive an annual base salary of $400,000, a target annual bonus of $350,000 (prorated for 2025), and, for fiscal 2026, eligibility for long-term equity awards with a target grant date fair value of at least $600,000, split between time-based restricted shares and performance-based restricted stock units. He will also receive a one-time time-based restricted stock award with a grant date fair value of $200,000 that vests over three years.
If Mr. Babin resigns for Good Reason or is terminated without Cause outside a change in control period, he is entitled to base benefits plus a cash severance equal to 1.0x his then-current base salary paid over 24 months and up to 12 months of healthcare premium reimbursement; during a change in control period, the severance increases to 2.0x his then-current base salary plus target bonus, paid in a lump sum, with full vesting of time-based equity. Mr. Lappetito’s separation agreement provides cash equal to his 2025 base salary and target bonus plus his guaranteed 2025 target bonus, full vesting of time-based equity, continued vesting of a prorated portion of performance-based equity, and up to 18 months of COBRA premium payments, alongside non-compete and non-solicitation covenants.
National Healthcare Properties, Inc. furnished a current report announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The company stated the information under Item 2.02 and Exhibit 99.1 is being furnished, not filed, under the Securities Exchange Act of 1934. The filing also lists the company’s preferred stock listings: 7.375% Series A (NHPAP) and 7.125% Series B (NHPBP) on The Nasdaq Global Market.
National Healthcare Properties, Inc. reported a narrower quarterly loss while continuing to streamline its balance sheet. For Q3, revenue from tenants was $86.0 million versus $88.9 million a year ago, and net loss attributable to common stockholders was $15.9 million (basic and diluted EPS $(0.56)), improving from $44.1 million last year. Year to date, revenue from tenants was $257.8 million, with a net loss attributable to common stockholders of $45.1 million.
Total assets were $1.74 billion, down from $1.95 billion at year-end, reflecting property sales and lower real estate balances. Net real estate investments declined to $1.54 billion. Debt balances included mortgage notes payable, net of $696.8 million, and Fannie Mae secured debt of $336.2 million. Operating expenses benefited from the absence of related-party operating and termination fees seen in 2024, partially offset by $6.6 million of Q3 impairment charges. The company recorded a Q3 gain on sale of real estate of $0.6 million and year-to-date gains of $28.3 million.
Cash from operations was a modest use of $3.0 million year to date, while investing provided $73.1 million (driven by $90.3 million of sale proceeds). Financing used $41.7 million, including debt repayments and preferred stock repurchases. As of October 30, 2025, common shares outstanding were 28,426,694.
FAQ
What is the current stock price of National Healthcare Properties (NHPBP)?
